Diagnosing Sleep Apnea
                     Diagnosing Sleep Apnea
Comprehensive Sleep Apnea Diagnosis & 
Management Program Designed to 
Optimize Patient Outcomes
Undiagnosed sleep apnea is a major 
comorbidity of CVD and a significant risk 
factor for stroke, CAD, CHF and AFib4.
Sleep apnea puts an enormous strain on the heart 
and remodels the cardiac substrate through 
stretching, oxidative stress and frequent 
sympathetic surges5.
Diagnosing sleep apnea at home with the 
WatchPAT® home sleep apnea diagnosis device 
improves compliance leading to better patient 
outcomes.
AHA recommends that screening for sleep apnea 
risk should be integrated into routine clinical care6.
The use of CPAP is associated with a 42% relative 
risk reduction in AFib recurrence in patients with 
OSA.
This reduction of AFib recurrence appears to be 
independent of medical or catheter ablation 
therapy. These results advocate for active 
screening for undiagnosed OSA in patients with 
AFib when OSA is clinically suspected7.
A simple yes/no questionnaire called STOP-BANG 
takes just a few minutes to identify those patients 
with a high probability of obstructive sleep apnea.